Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.

Walker RG, Poggioli T, Katsimpardi L, Buchanan SM, Oh J, Wattrus S, Heidecker B, Fong YW, Rubin LL, Ganz P, Thompson TB, Wagers AJ, Lee RT.

Circ Res. 2016 Apr 1;118(7):1125-42. doi: 10.1161/CIRCRESAHA.116.308391.

PMID:
27034275
2.

Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl₄-Induced Skeletal Muscle Injury.

Hwang OK, Park JK, Lee EJ, Lee EM, Kim AY, Jeong KS.

Int J Mol Sci. 2016 Feb 8;17(2):227. doi: 10.3390/ijms17020227.

3.

Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas.

Morales MG, Abrigo J, Acuña MJ, Santos RA, Bader M, Brandan E, Simon F, Olguin H, Cabrera D, Cabello-Verrugio C.

Dis Model Mech. 2016 Apr 1;9(4):441-9. doi: 10.1242/dmm.023390. Epub 2016 Feb 5.

4.

Knockout of Angiotensin AT2 receptors accelerates healing but impairs quality.

Faghih M, Hosseini SM, Smith B, Ansari AM, Lay F, Ahmed AK, Inagami T, Marti GP, Harmon JW, Walston JD, Abadir PM.

Aging (Albany NY). 2015 Dec;7(12):1185-97.

PMID:
26727887
Free PMC Article
5.

Pharmacological perspectives in sarcopenia: a potential role for renin-angiotensin system blockers?

Sartiani L, Spinelli V, Laurino A, Blescia S, Raimondi L, Cerbai E, Mugelli A.

Clin Cases Miner Bone Metab. 2015 May-Aug;12(2):135-8. doi: 10.11138/ccmbm/2015.12.2.135. Epub 2015 Oct 26. Review.

6.

Angiotensin II receptor blockade promotes repair of skeletal muscle through down-regulation of aging-promoting C1q expression.

Yabumoto C, Akazawa H, Yamamoto R, Yano M, Kudo-Sakamoto Y, Sumida T, Kamo T, Yagi H, Shimizu Y, Saga-Kamo A, Naito AT, Oka T, Lee JK, Suzuki J, Sakata Y, Uejima E, Komuro I.

Sci Rep. 2015 Sep 25;5:14453. doi: 10.1038/srep14453.

7.

Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma.

Quigley HA, Pitha IF, Welsbie DS, Nguyen C, Steinhart MR, Nguyen TD, Pease ME, Oglesby EN, Berlinicke CA, Mitchell KL, Kim J, Jefferys JJ, Kimball EC.

PLoS One. 2015 Oct 27;10(10):e0141137. doi: 10.1371/journal.pone.0141137. eCollection 2015.

8.

AT1 receptor blocker losartan protects against mechanical ventilation-induced diaphragmatic dysfunction.

Kwon OS, Smuder AJ, Wiggs MP, Hall SE, Sollanek KJ, Morton AB, Talbert EE, Toklu HZ, Tumer N, Powers SK.

J Appl Physiol (1985). 2015 Nov 15;119(10):1033-41. doi: 10.1152/japplphysiol.00237.2015. Epub 2015 Sep 10.

PMID:
26359481
9.

Modifier genes and their effect on Duchenne muscular dystrophy.

Vo AH, McNally EM.

Curr Opin Neurol. 2015 Oct;28(5):528-34. doi: 10.1097/WCO.0000000000000240. Review.

PMID:
26263473
10.

Muscle atrophy and fatty infiltration after an acute rotator cuff repair in a sheep model.

Luan T, Liu X, Easley JT, Ravishankar B, Puttlitz C, Feeley BT.

Muscles Ligaments Tendons J. 2015 Jul 3;5(2):106-12. eCollection 2015 Apr-Jun.

11.

Mechanisms of Cachexia in Chronic Disease States.

Yoshida T, Delafontaine P.

Am J Med Sci. 2015 Oct;350(4):250-6. doi: 10.1097/MAJ.0000000000000511.

PMID:
26083652
12.

Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1A.

Elbaz M, Yanay N, Laban S, Rabie M, Mitrani-Rosenbaum S, Nevo Y.

Cell Death Dis. 2015 Mar 12;6:e1690. doi: 10.1038/cddis.2015.60.

13.

Chronic wound repair and healing in older adults: current status and future research.

Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, DiPietro L, Falanga V, Fife C, Gardner S, Grice E, Harmon J, Hazzard WR, High KP, Houghton P, Jacobson N, Kirsner RS, Kovacs EJ, Margolis D, McFarland Horne F, Reed MJ, Sullivan DH, Thom S, Tomic-Canic M, Walston J, Whitney JA, Williams J, Zieman S, Schmader K.

J Am Geriatr Soc. 2015 Mar;63(3):427-38. doi: 10.1111/jgs.13332. Epub 2015 Mar 6.

14.

Chronic wound repair and healing in older adults: current status and future research.

Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, DiPietro L, Falanga V, Fife C, Gardner S, Grice E, Harmon J, Hazzard WR, High KP, Houghton P, Jacobson N, Kirsner RS, Kovacs EJ, Margolis D, McFarland Horne F, Reed MJ, Sullivan DH, Thom S, Tomic-Canic M, Walston J, Whitney J, Williams J, Zieman S, Schmader K.

Wound Repair Regen. 2015 Jan-Feb;23(1):1-13. doi: 10.1111/wrr.12245. Epub 2015 Feb 13.

15.

Pharmacology of manipulating lean body mass.

Sepulveda PV, Bush ED, Baar K.

Clin Exp Pharmacol Physiol. 2015 Jan;42(1):1-13. doi: 10.1111/1440-1681.12320. Review.

16.

Managing sarcopenia and its related-fractures to improve quality of life in geriatric populations.

Hida T, Harada A, Imagama S, Ishiguro N.

Aging Dis. 2013 Nov 26;5(4):226-37. doi: 10.14336/AD.2014.0500226. eCollection 2014 Aug. Review.

17.

Losartan improves measures of activity, inflammation, and oxidative stress in older mice.

Lin CH, Yang H, Xue QL, Chuang YF, Roy CN, Abadir P, Walston JD.

Exp Gerontol. 2014 Oct;58:174-8. doi: 10.1016/j.exger.2014.07.017. Epub 2014 Jul 28.

18.

Mechanisms of muscle wasting in chronic kidney disease.

Wang XH, Mitch WE.

Nat Rev Nephrol. 2014 Sep;10(9):504-16. doi: 10.1038/nrneph.2014.112. Epub 2014 Jul 1. Review.

19.

Understanding the process of fibrosis in Duchenne muscular dystrophy.

Kharraz Y, Guerra J, Pessina P, Serrano AL, Muñoz-Cánoves P.

Biomed Res Int. 2014;2014:965631. doi: 10.1155/2014/965631. Epub 2014 May 4. Review.

20.

Renin angiotensin system modulates mTOR pathway through AT2R in HIVAN.

Rai P, Lederman R, Haque S, Rehman S, Kumar V, Sataranatrajan K, Malhotra A, Kasinath BS, Singhal PC.

Exp Mol Pathol. 2014 Jun;96(3):431-7. doi: 10.1016/j.yexmp.2014.04.004. Epub 2014 Apr 21.

Items per page

Supplemental Content

Write to the Help Desk